1. Home
  2. TLN vs NBIX Comparison

TLN vs NBIX Comparison

Compare TLN & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLN

Talen Energy Corporation

HOLD

Current Price

$344.34

Market Cap

14.2B

Sector

Utilities

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$131.88

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLN
NBIX
Founded
2015
1992
Country
United States
United States
Employees
1880
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
13.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
TLN
NBIX
Price
$344.34
$131.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
22
Target Price
$433.50
$180.82
AVG Volume (30 Days)
630.3K
1.0M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.95
EPS
N/A
4.67
Revenue
N/A
$161,626,000.00
Revenue This Year
$85.30
$24.73
Revenue Next Year
$10.97
$13.14
P/E Ratio
$83.51
$28.58
Revenue Growth
N/A
977.51
52 Week Low
$194.54
$100.83
52 Week High
$451.28
$160.18

Technical Indicators

Market Signals
Indicator
TLN
NBIX
Relative Strength Index (RSI) 53.46 51.80
Support Level $305.56 $124.29
Resistance Level $345.29 $136.23
Average True Range (ATR) 14.89 4.36
MACD 4.83 0.20
Stochastic Oscillator 61.96 72.29

Price Performance

Historical Comparison
TLN
NBIX

About TLN Talen Energy Corporation

Talen Energy Corp is an independent power producer and energy infrastructure company based in the United States. It owns and operates several gigawatts of power infrastructure in the United States, including 2.2GW of nuclear power and a dispatchable fossil fleet. The company produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic, Ohio, and Montana. Talen's operating segments are: PJM and Others. The PJM segment, which generates maximum revenue, is engaged in electricity generation, marketing activities, and commodity risk and fuel management within the PJM market and is comprised of Susquehanna and Talen's natural gas and coal generation facilities in PJM.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: